About CraniUS Therapeutics
CraniUS Therapeutics is a private company based in Baltimore, Maryland, incorporated in 2021 in Maryland. It has reported $38,420,000 raised in two offerings on Form D since August 2021. Its chief executive is Michael Maglin.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Feb 13, 2026 | Mar 6, 2026 | $19,000,000of $20.0M target | 49 | $387K | EquityRule 506(b) | Form D ↗ |
| Aug 19, 2021 | Aug 20, 2021amended May 25, 2022 | $19,420,000of $20.0M target | 21 | $924K | EquityRule 506(b) | Form D/A ↗3 earlier filings |
| Total, two offerings | $38,420,000 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on CraniUS Therapeutics's Form D filed Mar 6, 2026.
MM
ES
Elliot Stone
Director
SK
Steven Klasko
Director
BF
Brett Friedman
Director
OJ
JS
Joshua Scheinker
Director
SW
CG
BM
Brian Moran
Director
Earlier filings also listed Henry Brem (director, last listed May 2022), H Friedman (director, last listed May 2022) and Deborah Weidman (executive officer, last listed May 2022).